Bharat Biotech forays into CRDMO space with new cell & gene therapies arm Nucelion Therapeutics
HYDERABAD: Vaccine maker Bharat Biotech is foraying into the contract research development and manufacturing organisation (CDRMO) space with the setting up of a new wholly-owned subsidiary, Nucelion Therapeutics Pvt Ltd, that is focused on cell and gene therapies (CGT).Announcing its entry into this high growth CRDMO segment, Bharat Biotech said the new entity will support…
